Press Release: MenoScan.org National Consortium launch

FOR IMMEDIATE RELEASE
Media Relations – MENOSCAN.org
Email: editor.prevention101@gmail.com | Phone: 516.522.0777

The AngioInstitute (501c3) 121 E60th St. #6A  New York, NY 10022

www.angioinstitute.org

---

MENOSCAN.org Launches National Consortium to Advance Diagnosis, Treatment, and Legislative Action for Women’s Midlife Disorders

New York 8/12/2025 — The AngioInstitute (501c3), a nonprofit organization dedicated to advancing public health through non-invasive diagnostics and education, has launched MENOSCAN.org, a national consortium of leading medical professionals committed to transforming women’s midlife health care. Bringing together experts in diagnostic imaging, endocrinology, psychiatry, and integrative medicine, MENOSCAN is advancing clinical diagnostics, public education, and legislative advocacy to improve early detection and treatment for the many health challenges faced during perimenopause and menopause.

The national collaborative unites experts across multiple disciplines, including:

· DR. ANGELA MAZZA (FLA), endocrinologist and chief clinical advisor to THYROIDSCAN.org, known for her integrative approach to hormonal and thyroid health.

· DR. ROBERT BARD (NYC), diagnostic imaging specialist recognized for advancing non-invasive medical technologies for early disease detection and diagnostic modalities for clinical research.

·  DR. LESLIE VALLE-MONTOYA, physician and bioenergy research specialist applying advanced metabolic health protocols to support perimenopausal women, focusing on restoring balance through innovative, non-invasive therapies.

· DR. BARBARA BARTLIK, leading integrative psychiatrist addressing the intersection of mental, emotional, and physical wellness in women’s health.

Their shared goal: to “advance the needle” on identifying and treating midlife disorders in the clinical stage, where intervention can prevent long-term disability, improve quality of life, and reduce healthcare costs. “Women in midlife are often told their symptoms are ‘just part of aging,’” says Dr. Angela Mazza. “We now have the technology and clinical insight to intervene earlier, and we must make these tools available to everyone — not just those who can afford them.”

 

TARGETING THE FULL SPECTRUM OF MIDLIFE DISORDERS

MENOSCAN.org addresses the interconnected health challenges faced by women in midlife — many of which remain underdiagnosed or undertreated due to fragmented care and outdated insurance policies. The program focuses on seven critical areas:

1. Cardiovascular Disease (CVD) – the leading cause of death in women, often overlooked during the menopause transition.

2. Breast and Reproductive Health – enhanced screening and education to reduce late-stage diagnoses.

3. Osteoporosis and Bone Health – early imaging and preventive care to reduce fracture risk.

4. Cognitive Decline and Brain Health – strategies for identifying early neurological changes.

5.Hormonal & Thyroid Function – advanced diagnostics to guide more personalized treatment plans.

6. Metabolic Syndrome and Weight Gain – addressing the root causes of midlife metabolic shifts.

7. Emotional & Mental Health – integrative care for depression, anxiety, and mood instability during menopause.

---

 

FROM THE CLINIC TO THE CAPITOL: LEGISLATIVE ADVOCACY

Beyond its clinical mission, MENOSCAN.org is building a national movement to demand better access, insurance coverage, and resources for women’s health during midlife. Spearheading this effort is Dr. Lennard Goetze, executive director and founder of the Women’s Health Professional Network and the AngioInstitute (501c3).

Dr. Goetze is leading a state-by-state outreach campaign to legislators, focusing on those who have already introduced or are considering bills addressing women’s health and menopause-related care. Proposals have already been submitted in New York, New Jersey, Florida, California, and Colorado, with the goal of creating model legislation for nationwide adoption. “Our mission is to ensure that early diagnosis, advanced screening technologies, and integrative care become standard, insured, and accessible for all women — not a privilege for the few,” says Dr. Goetze. “We are meeting with lawmakers to turn this vision into enforceable policy.”

A PUBLIC HEALTH IMPERATIVE

The stakes are high. Midlife health disorders not only impact longevity and quality of life, they also carry significant economic costs, affecting workplace productivity and increasing long-term healthcare expenditures. Dr. Robert Bard underscores the urgency: “We have decades of data linking early intervention to better health outcomes, yet too many women are falling through the cracks. MENOSCAN is bridging the gap between what medicine can do and what patients actually receive.”

---

MENOSCAN.org is a collaborative platform dedicated to advancing clinical diagnostics, education, and legislative reform for midlife women’s health. By bringing together specialists in cardiology, endocrinology, psychiatry, oncology, bone health, and integrative medicine, MENOSCAN provides a multidisciplinary approach to prevention, early detection, and treatment.

Through partnerships with healthcare providers, advocacy groups, and policymakers, MENOSCAN is creating a roadmap for comprehensive midlife care — one that addresses the biological, emotional, and social challenges women face during perimenopause and menopause.

For more information, visit www.MENOSCAN.org